LeMaitre Vascular
(NASDAQ:LMAT)
$67.20
0[0.00%]
At close: Mar 27
$67.20
0[0.00%]
PreMarket: 4:00PM EDT
Consensus Rating1
Neutral
Highest Price Target1
$69.00
Lowest Price Target1
$69.00
Consensus Price Target1
$56.75

LeMaitre Vascular Stock (NASDAQ:LMAT), Analyst Ratings, Price Targets, Predictions

LeMaitre Vascular Inc has a consensus price target of $56.75, established from looking at the 12 latest analyst ratings. The last 3 analyst ratings were released from Barrington Research, Keybanc, and JMP Securities on February 28, 2024, February 6, 2024, and October 23, 2023. With an average price target of $43 between Barrington Research, Keybanc, and JMP Securities, there's an implied -36.01% downside for LeMaitre Vascular Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Oct 23
0
0
0
0
0
Feb
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Barrington Research
Keybanc
JMP Securities
Oppenheimer
Jefferies

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for LeMaitre Vascular

date
▲▼
ticker
▲▼
Buy Now
Company
▲▼
Current price
▲▼
Upside/Downside
▲▼
Analyst Firm
▲▼
Analyst & % Accurate
▲▼
Price Target Change
▲▼
Rating Change
▲▼
Previous / Current Rating
▲▼
Get Alert
02/28/2024LMATBuy Now
LeMaitre Vascular
$67.202.68%Barrington Research
Michael Petusky
$66 → $69MaintainsOutperformGet Alert
02/06/2024LMATBuy Now
LeMaitre Vascular
$67.20—Keybanc
Brett Fishbin
—Initiates → Sector WeightGet Alert
10/23/2023LMATBuy Now
LeMaitre Vascular
$67.20-10.71%JMP Securities
Daniel Stauder
→ $60Initiates → Market OutperformGet Alert
09/06/2023LMATBuy Now
LeMaitre Vascular
$67.204.17%Oppenheimer
Suraj Kalia
→ $70Initiates → OutperformGet Alert
08/03/2023LMATBuy Now
LeMaitre Vascular
$67.20-0.3%Jefferies
Anthony Petrone
$63 → $67DowngradeBuy → HoldGet Alert
08/02/2023LMATBuy Now
LeMaitre Vascular
$67.2011.61%Lake Street
Brooks O'Neil
$65 → $75MaintainsBuyGet Alert
08/02/2023LMATBuy Now
LeMaitre Vascular
$67.20-1.79%Barrington Research
Michael Petusky
$62 → $66MaintainsOutperformGet Alert
05/03/2023LMATBuy Now
LeMaitre Vascular
$67.20-7.74%Barrington Research
Michael Petusky
→ $62UpgradeMarket Perform → OutperformGet Alert
10/28/2022LMATBuy Now
LeMaitre Vascular
$67.20—Barrington Research
Michael Petusky
—DowngradeOutperform → Market PerformGet Alert
09/16/2021LMATBuy Now
LeMaitre Vascular
$67.204.17%Jefferies
Anthony Petrone
—Initiates → BuyGet Alert
08/03/2021LMATBuy Now
LeMaitre Vascular
$67.20-13.69%Roth Capital
Scott Henry
—MaintainsNeutralGet Alert
05/04/2021LMATBuy Now
LeMaitre Vascular
$67.20-18.15%Roth Capital——MaintainsNeutralGet Alert

FAQ

Q

What is the target price for LeMaitre Vascular (LMAT)?

A

The latest price target for LeMaitre Vascular (NASDAQ: LMAT) was reported by Barrington Research on February 28, 2024. The analyst firm set a price target for $69.00 expecting LMAT to rise to within 12 months (a possible 2.68% upside). 8 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for LeMaitre Vascular (LMAT)?

A

The latest analyst rating for LeMaitre Vascular (NASDAQ: LMAT) was provided by Barrington Research, and LeMaitre Vascular maintained their outperform rating.

Q

When was the last upgrade for LeMaitre Vascular (LMAT)?

A

The last upgrade for LeMaitre Vascular Inc happened on May 3, 2023 when Barrington Research raised their price target to $62. Barrington Research previously had a market perform for LeMaitre Vascular Inc.

Q

When was the last downgrade for LeMaitre Vascular (LMAT)?

A

The last downgrade for LeMaitre Vascular Inc happened on August 3, 2023 when Jefferies changed their price target from $63 to $67 for LeMaitre Vascular Inc.

Q

When is the next analyst rating going to be posted or updated for LeMaitre Vascular (LMAT)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of LeMaitre Vascular, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for LeMaitre Vascular was filed on February 28, 2024 so you should expect the next rating to be made available sometime around February 28, 2025.

Q

Is the Analyst Rating LeMaitre Vascular (LMAT) correct?

A

While ratings are subjective and will change, the latest LeMaitre Vascular (LMAT) rating was a maintained with a price target of $66.00 to $69.00. The current price LeMaitre Vascular (LMAT) is trading at is $67.20, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch